Bankrupt 23Andme is facing a lawsuit for her plans to sell client genetic information.
Twenty -seven states and Colombia district took legal action this week against 23rds in the US bankruptcy court for the eastern district of Misuri, the court that oversees the bankruptcy procedures of chapter 11 that the genetic testing enterprise entered earlier during the year.
States claim that 23 ages has no right to sell their client genetic identity to the highest bidder “unless the company” first gets[s] express the informed consent of the transaction/transfer proposed by each impact consumer. “
They want the bankruptcy court to decide on “if and to what extent” the genetic testing company can “sell and transfer a third party such intimate data of clients without first receiving the informed consent of its clients”, according to the submission.
In the appearance, states said they were “not contrary to any sales”, but “claim that the consent, informed by each customer is needed before any data transfer is made”.
The attorneys general that filled the lawsuit represent Arizona, Colorado, Connecticut, The District of Columbia, Florida, Illinois, Kansas, Kentucky, Louisiana, Michigan, Minnesota, New Hampshire, New Mexico, New York, North Car Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.
“23 ORTHER CANNOT ACCESS MILLION OF PERSONAL GENETICS OF PEOPLE without their consent,” New York Attorney General Lettia James said in a statement.
“New Yorkers and many others all over the country entrusted 23As with their private information, and they have the right to know what to do with their information.”
A spokesman for 23rds told Fox Business that the arguments made by lawyers general in the lawsuit were “without merit”.
“The sale is allowed under 23rds of intimacy policies and the law in force,” the spokesman said.
“We demanded that every bidder approve our policies and respect the applicable law as a condition to participate in our sales process. Consumers will continue to have the same rights and protection in the hands of the winning bidder.”
Remaining bidders, Regeneron Pharmaceuticals and the TTAM Research Institute, “have been committed to respecting 23 -II intimacy policies, and will continue to operate 23 -OR as always operated,” according to the 23rd spokesman.
In May, New York -based Regeneron announced that the successful bidder in auction for “essentially” all “$ 23 -million bid was appointed.
23Andme then received a $ 305 million offer from the TTAM Institute of Research founded by Anne Wojcicki, setting the stage for another auction.
The genetic test company entered Chapter 11 bankruptcy in March to facilitate a sale of its business.
In its bankruptcy petition, the company valued a range of 100 million to $ 500 million for its assets, with liabilities estimated in the same range.
23 ORDER was originally founded in 2006.
#States #legal #actions #ages #attempts #sell #genetic #information #client #bankruptcy
Image Source : nypost.com